Portfolio Holdings Detail for ISIN IE00BDZVHG35
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 63
Stock Name / Fund iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer Blackrock

ETF Ticker BTEE(USD) LSE
ETF Ticker BTEE.L(GBP) LSE

Holdings detail for IONS

Stock Name	Ionis Pharmaceuticals Inc
Ticker	IONS(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US4622221004
LEI	549300SI4ZGLG0BLUZ92

Show aggregate IONS holdings

News associated with IONS

How Will Vertex Pharmaceuticals Stock React To Its Upcoming Earnings?: Vertex Pharmaceuticals (NASDAQ:VRTX) is scheduled to announce its earnings on Monday, May 5, 2025. For event-driven traders, understanding historical stock performance around earnings releases can be beneficial. Over the past five years, VRTX has experienced a positive one-day re - 2025-05-05 03:21:14
Ionis Pharmaceuticals (NASDAQ:IONS) Shares Gap Up on Better-Than-Expected Earnings: Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Free Report)’s stock price gapped up prior to trading on Wednesday following a stronger than expected earnings report. The stock had previously closed at $29.81, but opened at $31.78. Ionis Pharmaceuticals shares last traded at $30.09, with a volume of 185,687 shares trading hands. The company reported ($0.93) EPS […] - 2025-05-02 05:10:54
Mariner LLC Has $967,000 Stake in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS): Mariner LLC raised its holdings in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Free Report) by 19.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 27,661 shares of the company’s stock after acquiring an additional 4,534 shares during the quarter. Mariner LLC’s holdings in […] - 2025-04-28 08:46:51
Raymond James Financial Inc. Purchases Shares of 105,619 Ionis Pharmaceuticals, Inc. (NASDAQ:IONS): Raymond James Financial Inc. purchased a new stake in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Free Report) in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 105,619 shares of the company’s stock, valued at approximately $3,692,000. Raymond James Financial Inc. owned about 0.07% of Ionis Pharmaceuticals […] - 2025-04-28 08:46:49
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Shares Sold by Envestnet Asset Management Inc.: Envestnet Asset Management Inc. cut its stake in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Free Report) by 10.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 52,688 shares of the company’s stock after selling 6,126 shares during the period. […] - 2025-04-28 07:37:03
Ionis Pharmaceuticals Sees Unusually High Options Volume (NASDAQ:IONS): Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Free Report) was the target of some unusual options trading on Monday. Stock traders bought 5,610 call options on the company. This is an increase of approximately 1,252% compared to the typical volume of 415 call options. Wall Street Analysts Forecast Growth IONS has been the subject of a […] - 2025-04-23 05:50:51
Brokerages Set Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Target Price at $56.72: Shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Free Report) have earned an average recommendation of “Moderate Buy” from the twenty brokerages that are presently covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, six have issued a hold rating, eleven have issued a buy rating and […] - 2025-04-21 05:46:52
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Holdings Cut by LPL Financial LLC: LPL Financial LLC lessened its stake in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Free Report) by 5.3% in the 4th quarter, HoldingsChannel.com reports. The fund owned 40,376 shares of the company’s stock after selling 2,244 shares during the period. LPL Financial LLC’s holdings in Ionis Pharmaceuticals were worth $1,412,000 as of its most recent […] - 2025-04-18 08:58:49
CIBC Private Wealth Group LLC Sells 1,300 Shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS): CIBC Private Wealth Group LLC reduced its stake in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Free Report) by 53.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,125 shares of the company’s stock after selling 1,300 shares during the quarter. CIBC […] - 2025-04-10 08:15:01
Ionis Pharmaceuticals (NASDAQ:IONS) Upgraded to Strong-Buy at HC Wainwright: HC Wainwright upgraded shares of Ionis Pharmaceuticals (NASDAQ:IONS – Free Report) to a strong-buy rating in a report issued on Monday, Marketbeat reports. The firm currently has $45.00 price target on the stock. A number of other brokerages also recently commented on IONS. Royal Bank of Canada reiterated an “outperform” rating and set a $70.00 […] - 2025-04-10 06:07:15
California Public Employees Retirement System Decreases Stock Holdings in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS): California Public Employees Retirement System lessened its holdings in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Free Report) by 9.3% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 192,130 shares of the company’s stock after selling 19,626 shares during the period. California Public […] - 2025-04-08 08:22:51
Schroder Investment Management Group Has $3.52 Million Position in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS): Schroder Investment Management Group lessened its stake in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Free Report) by 98.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 100,659 shares of the company’s stock after selling 4,830,563 shares during the […] - 2025-04-06 08:30:50
Blair William & Co. IL Has $1.39 Million Stock Holdings in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS): Blair William & Co. IL lowered its stake in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Free Report) by 14.5% during the fourth quarter, Holdings Channel.com reports. The fund owned 39,882 shares of the company’s stock after selling 6,769 shares during the period. Blair William & Co. IL’s holdings in Ionis Pharmaceuticals were worth $1,394,000 as of […] - 2025-04-03 08:28:55
Ionis Pharmaceuticals (NASDAQ:IONS) Coverage Initiated at Redburn Atlantic: Research analysts at Redburn Atlantic began coverage on shares of Ionis Pharmaceuticals (NASDAQ:IONS – Get Free Report) in a report released on Monday, Marketbeat Ratings reports. The brokerage set a “neutral” rating and a $39.00 price target on the stock. Redburn Atlantic’s price objective would suggest a potential upside of 43.07% from the stock’s current […] - 2025-04-02 06:11:00
Vanguard Group Inc. Has $575.88 Million Stake in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS): Vanguard Group Inc. increased its stake in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Free Report) by 9.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 16,472,539 shares of the company’s stock after purchasing an additional 1,416,781 shares during the quarter. Vanguard […] - 2025-04-01 08:27:05
KLP Kapitalforvaltning AS Acquires Shares of 29,200 Ionis Pharmaceuticals, Inc. (NASDAQ:IONS): KLP Kapitalforvaltning AS bought a new position in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Free Report) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 29,200 shares of the company’s stock, valued at approximately $1,021,000. Other large investors also recently modified their holdings […] - 2025-03-31 07:56:52
Natixis Advisors LLC Sells 6,767 Shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS): Natixis Advisors LLC lowered its stake in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Free Report) by 32.1% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 14,313 shares of the company’s stock after selling 6,767 shares during the quarter. Natixis Advisors LLC’s holdings in Ionis Pharmaceuticals were worth $500,000 at the end of […] - 2025-03-28 08:38:50
Brokerages Set Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Price Target at $59.56: Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Free Report) has earned an average rating of “Moderate Buy” from the twenty research firms that are covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, five have issued a hold recommendation, thirteen have given a buy recommendation and one has issued […] - 2025-03-27 05:48:54
Xponance Inc. Acquires 318 Shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS): Xponance Inc. increased its holdings in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Free Report) by 1.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 19,339 shares of the company’s stock after purchasing an additional 318 shares during the period. Xponance Inc.’s […] - 2025-03-26 08:34:58
Signaturefd LLC Purchases 584 Shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS): Signaturefd LLC lifted its position in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Free Report) by 160.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 949 shares of the company’s stock after purchasing an additional 584 shares during the period. Signaturefd […] - 2025-03-26 07:48:47
Ionis Pharmaceuticals (NASDAQ:IONS) Price Target Cut to $45.00 by Analysts at JPMorgan Chase & Co.: Ionis Pharmaceuticals (NASDAQ:IONS – Free Report) had its price objective lowered by JPMorgan Chase & Co. from $47.00 to $45.00 in a research report released on Monday,Benzinga reports. JPMorgan Chase & Co. currently has a neutral rating on the stock. A number of other research firms also recently issued reports on IONS. StockNews.com raised Ionis […] - 2025-03-25 05:55:00
Ionis Pharmaceuticals (NASDAQ:IONS) Upgraded to Sell at StockNews.com: Ionis Pharmaceuticals (NASDAQ:IONS – Get Free Report) was upgraded by analysts at StockNews.com to a “sell” rating in a research note issued to investors on Tuesday. Several other analysts have also issued reports on the company. JPMorgan Chase & Co. lowered their target price on Ionis Pharmaceuticals from $51.00 to $47.00 and set a “neutral” […] - 2025-03-20 05:44:55
Arizona State Retirement System Has $1.44 Million Position in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS): Arizona State Retirement System raised its position in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Free Report) by 8.8% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 41,147 shares of the company’s stock after acquiring an additional 3,320 shares during the quarter. […] - 2025-03-13 08:48:49
Jones Financial Companies Lllp Acquires 2,614 Shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS): Jones Financial Companies Lllp boosted its holdings in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Free Report) by 38.9% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 9,338 shares of the company’s stock after buying an additional 2,614 shares during the period. Jones Financial Companies […] - 2025-03-12 08:03:05
Principal Financial Group Inc. Has $476,000 Stock Holdings in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS): Principal Financial Group Inc. increased its position in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Free Report) by 3.8% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 13,616 shares of the company’s stock after acquiring an additional 504 shares during the quarter. Principal Financial Group Inc.’s holdings in Ionis Pharmaceuticals were worth $476,000 at the […] - 2025-03-07 08:16:55
Amalgamated Bank Acquires 335 Shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS): Amalgamated Bank lifted its holdings in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Free Report) by 3.4% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 10,292 shares of the company’s stock after acquiring an additional 335 shares during the period. Amalgamated Bank’s […] - 2025-03-05 10:26:53
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Shares Sold by Y Intercept Hong Kong Ltd: Y Intercept Hong Kong Ltd lessened its stake in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Free Report) by 53.3% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 9,407 shares of the company’s stock after selling 10,734 shares during the period. Y Intercept Hong Kong […] - 2025-03-04 08:28:56
Van ECK Associates Corp Raises Stock Holdings in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS): Van ECK Associates Corp raised its holdings in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Free Report) by 4.4% in the 4th quarter, HoldingsChannel.com reports. The fund owned 61,619 shares of the company’s stock after buying an additional 2,613 shares during the quarter. Van ECK Associates Corp’s holdings in Ionis Pharmaceuticals were worth $2,154,000 as […] - 2025-02-21 08:16:55
Ionis Pharma Beats Expectations for Q4: Ionis Pharmaceuticals (NASDAQ:IONS), a leader in RNA-targeted drug discovery and development, announced its earnings results for the fourth quarter on Feb. 19. The report revealed that Ionis outperformed analysts' top-line expectations with revenue of $227 million compared to the - 2025-02-19 18:26:55
Analysts Forecast 14% Upside For The Holdings of IWS: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-02-17 16:19:50

iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) IONS holdings

Date	Number of IONS Shares Held	Base Market Value of IONS Shares	Local Market Value of IONS Shares	Change in IONS Shares Held	Change in IONS Base Value	Current Price per IONS Share Held	Previous Price per IONS Share Held
2025-05-08 (Thursday)	75,699	USD 2,479,142	USD 2,479,142	0	USD -24,224	USD 32.75	USD 33.07
2025-05-07 (Wednesday)	75,699	USD 2,503,366	USD 2,503,366	0	USD 91,596	USD 33.07	USD 31.86
2025-05-06 (Tuesday)	75,699	USD 2,411,770	USD 2,411,770	0	USD -135,123	USD 31.86	USD 33.645
2025-05-05 (Monday)	75,699	USD 2,546,893	USD 2,546,893	0	USD 65,480	USD 33.645	USD 32.78
2025-05-02 (Friday)	75,699	USD 2,481,413	USD 2,481,413	0	USD 80,998	USD 32.78	USD 31.71
2025-05-01 (Thursday)	75,699	USD 2,400,415	USD 2,400,415	0	USD 75,699	USD 31.71	USD 30.71
2025-04-30 (Wednesday)	75,699	USD 2,324,716	USD 2,324,716	0	USD 68,129	USD 30.71	USD 29.81
2025-04-29 (Tuesday)	75,699	USD 2,256,587	USD 2,256,587	0	USD 5,299	USD 29.81	USD 29.74
2025-04-28 (Monday)	75,699	USD 2,251,288	USD 2,251,288	0	USD 3,028	USD 29.74	USD 29.7
2025-04-25 (Friday)	75,699	USD 2,248,260	USD 2,248,260	0	USD 9,841	USD 29.7	USD 29.57
2025-04-24 (Thursday)	75,699	USD 2,238,419	USD 2,238,419	0	USD 35,578	USD 29.57	USD 29.1
2025-04-23 (Wednesday)	75,699	USD 2,202,841	USD 2,202,841	264	USD 12,963	USD 29.1	USD 29.03
2025-04-22 (Tuesday)	75,435	USD 2,189,878	USD 2,189,878	0	USD 39,226	USD 29.03	USD 28.51
2025-04-21 (Monday)	75,435	USD 2,150,652	USD 2,150,652	0	USD 8,298	USD 28.51	USD 28.4
2025-04-18 (Friday)	75,435	USD 2,142,354	USD 2,142,354	0	USD 0	USD 28.4	USD 28.4
2025-04-17 (Thursday)	75,435	USD 2,142,354	USD 2,142,354	0	USD 3,772	USD 28.4	USD 28.35
2025-04-16 (Wednesday)	75,435	USD 2,138,582	USD 2,138,582	0	USD -2,263	USD 28.35	USD 28.38
2025-04-15 (Tuesday)	75,435	USD 2,140,845	USD 2,140,845	0	USD -22,631	USD 28.38	USD 28.68
2025-04-14 (Monday)	75,435	USD 2,163,476	USD 2,163,476	0	USD 58,839	USD 28.68	USD 27.9
2025-04-11 (Friday)	75,435	USD 2,104,637	USD 2,104,637	0	USD 89,768	USD 27.9	USD 26.71
2025-04-10 (Thursday)	75,435	USD 2,014,869	USD 2,014,869	-2,112	USD -138,611	USD 26.71	USD 27.77
2025-04-09 (Wednesday)	77,547	USD 2,153,480	USD 2,153,480	0	USD 175,256	USD 27.77	USD 25.51
2025-04-08 (Tuesday)	77,547	USD 1,978,224	USD 1,978,224	-264	USD -167,025	USD 25.51	USD 27.57
2025-04-07 (Monday)	77,811	USD 2,145,249	USD 2,145,249	-264	USD 30,197	USD 27.57	USD 27.09
2025-04-04 (Friday)	78,075	USD 2,115,052	USD 2,115,052	-1,320	USD -164,378	USD 27.09	USD 28.71
2025-04-02 (Wednesday)	79,395	USD 2,279,430	USD 2,279,430	0	USD 115,122	USD 28.71	USD 27.26
2025-04-01 (Tuesday)	79,395	USD 2,164,308	USD 2,164,308	2,314	USD -161,226	USD 27.26	USD 30.17
2025-03-31 (Monday)	77,081	USD 2,325,534	USD 2,325,534	-780	USD -99,836	USD 30.17	USD 31.15
2025-03-28 (Friday)	77,861	USD 2,425,370	USD 2,425,370	0	USD -44,381	USD 31.15	USD 31.72
2025-03-27 (Thursday)	77,861	USD 2,469,751	USD 2,469,751	0	USD 17,908	USD 31.72	USD 31.49
2025-03-26 (Wednesday)	77,861	USD 2,451,843	USD 2,451,843	0	USD -60,731	USD 31.49	USD 32.27
2025-03-25 (Tuesday)	77,861	USD 2,512,574	USD 2,512,574	0	USD -91,876	USD 32.27	USD 33.45
2025-03-24 (Monday)	77,861	USD 2,604,450	USD 2,604,450	0	USD 42,044	USD 33.45	USD 32.91
2025-03-21 (Friday)	77,861	USD 2,562,406	USD 2,562,406	3,911	USD 142,022	USD 32.91	USD 32.73
2025-03-20 (Thursday)	73,950	USD 2,420,384	USD 2,420,384	0	USD -45,109	USD 32.73	USD 33.34
2025-03-19 (Wednesday)	73,950	USD 2,465,493	USD 2,465,493	0	USD 28,840	USD 33.34	USD 32.95
2025-03-18 (Tuesday)	73,950	USD 2,436,653	USD 2,436,653	0	USD -99,832	USD 32.95	USD 34.3
2025-03-17 (Monday)	73,950	USD 2,536,485	USD 2,536,485	0	USD 99,093	USD 34.3	USD 32.96
2025-03-14 (Friday)	73,950	USD 2,437,392	USD 2,437,392	-3,968	USD -126,110	USD 32.96	USD 32.9
2025-03-13 (Thursday)	77,918	USD 2,563,502	USD 2,563,502	0	USD -39,738	USD 32.9	USD 33.41
2025-03-12 (Wednesday)	77,918	USD 2,603,240	USD 2,603,240	0	USD 29,608	USD 33.41	USD 33.03
2025-03-11 (Tuesday)	77,918	USD 2,573,632	USD 2,573,632	0	USD 63,114	USD 33.03	USD 32.22
2025-03-10 (Monday)	77,918	USD 2,510,518	USD 2,510,518	0	USD -123,890	USD 32.22	USD 33.81
2025-03-07 (Friday)	77,918	USD 2,634,408	USD 2,634,408	-494	USD -62,181	USD 33.81	USD 34.39
2025-03-06 (Thursday)	78,412	USD 2,696,589	USD 2,696,589	0	USD 50,184	USD 34.39	USD 33.75
2025-03-05 (Wednesday)	78,412	USD 2,646,405	USD 2,646,405	0	USD 62,730	USD 33.75	USD 32.95
2025-03-04 (Tuesday)	78,412	USD 2,583,675	USD 2,583,675	-247	USD 19,392	USD 32.95	USD 32.6
2025-03-03 (Monday)	78,659	USD 2,564,283	USD 2,564,283	0	USD -46,409	USD 32.6	USD 33.19
2025-02-28 (Friday)	78,659	USD 2,610,692	USD 2,610,692	0	USD 144,732	USD 33.19	USD 31.35
2025-02-27 (Thursday)	78,659	USD 2,465,960	USD 2,465,960	0	USD -32,250	USD 31.35	USD 31.76
2025-02-26 (Wednesday)	78,659	USD 2,498,210	USD 2,498,210	0	USD -7,079	USD 31.76	USD 31.85
2025-02-25 (Tuesday)	78,659	USD 2,505,289	USD 2,505,289	496	USD 12,671	USD 31.85	USD 31.89
2025-02-24 (Monday)	78,163	USD 2,492,618	USD 2,492,618	0	USD -33,610	USD 31.89	USD 32.32
2025-02-21 (Friday)	78,163	USD 2,526,228	USD 2,526,228	0	USD -28,920	USD 32.32	USD 32.69
2025-02-20 (Thursday)	78,163	USD 2,555,148	USD 2,555,148	0	USD 68,783	USD 32.69	USD 31.81
2025-02-19 (Wednesday)	78,163	USD 2,486,365	USD 2,486,365	-247	USD -18,835	USD 31.81	USD 31.95
2025-02-18 (Tuesday)	78,410	USD 2,505,200	USD 2,505,200	0	USD 71,354	USD 31.95	USD 31.04
2025-02-17 (Monday)	78,410	USD 2,433,846	USD 2,433,846	0	USD 0	USD 31.04	USD 31.04
2025-02-14 (Friday)	78,410	USD 2,433,846	USD 2,433,846	0	USD 54,102	USD 31.04	USD 30.35
2025-02-13 (Thursday)	78,410	USD 2,379,744	USD 2,379,744	741	USD -15,568	USD 30.35	USD 30.84
2025-02-12 (Wednesday)	77,669	USD 2,395,312	USD 2,395,312	247	USD -49,675	USD 30.84	USD 31.58
2025-02-11 (Tuesday)	77,422	USD 2,444,987	USD 2,444,987	988	USD 38,845	USD 31.58	USD 31.48
2025-02-10 (Monday)	76,434	USD 2,406,142	USD 2,406,142	0	USD 6,114	USD 31.48	USD 31.4
2025-02-07 (Friday)	76,434	USD 2,400,028	USD 2,400,028	0	USD -94,013	USD 31.4	USD 32.63
2025-02-06 (Thursday)	76,434	USD 2,494,041	USD 2,494,041	0	USD -41,275	USD 32.63	USD 33.17
2025-02-05 (Wednesday)	76,434	USD 2,535,316	USD 2,535,316	0	USD 116,944	USD 33.17	USD 31.64
2025-02-04 (Tuesday)	76,434	USD 2,418,372	USD 2,418,372	0	USD -37,452	USD 31.64	USD 32.13
2025-02-03 (Monday)	76,434	USD 2,455,824	USD 2,455,824	0	USD 17,579	USD 32.13	USD 31.9
2025-01-31 (Friday)	76,434	USD 2,438,245	USD 2,438,245	0	USD -108,536	USD 31.9	USD 33.32
2025-01-30 (Thursday)	76,434	USD 2,546,781	USD 2,546,781	0	USD 33,631	USD 33.32	USD 32.88
2025-01-29 (Wednesday)	76,434	USD 2,513,150	USD 2,513,150	0	USD -94,014	USD 32.88	USD 34.11
2025-01-28 (Tuesday)	76,434	USD 2,607,164	USD 2,607,164	0	USD 4,586	USD 34.11	USD 34.05
2025-01-27 (Monday)	76,434	USD 2,602,578	USD 2,602,578	0	USD -53,504	USD 34.05	USD 34.75
2025-01-24 (Friday)	76,434	USD 2,656,082	USD 2,656,082	0	USD 22,166	USD 34.75	USD 34.46
2025-01-23 (Thursday)	76,434	USD 2,633,916	USD 2,633,916	0	USD 149,811	USD 34.46	USD 32.5
2025-01-22 (Wednesday)	76,434	USD 2,484,105	USD 2,484,105
2025-01-21 (Tuesday)	76,434	USD 2,497,863	USD 2,497,863
2025-01-20 (Monday)	76,434	USD 2,402,321	USD 2,402,321
2025-01-17 (Friday)	76,434	USD 2,402,321	USD 2,402,321
2025-01-16 (Thursday)	75,446	USD 2,435,397	USD 2,435,397
2025-01-15 (Wednesday)	74,458	USD 2,472,750	USD 2,472,750
2025-01-14 (Tuesday)	74,458	USD 2,434,032	USD 2,434,032
2025-01-13 (Monday)	74,458	USD 2,601,563	USD 2,601,563
2025-01-10 (Friday)	74,458	USD 2,491,365	USD 2,491,365
2025-01-09 (Thursday)	74,952	USD 2,555,863	USD 2,555,863
2025-01-09 (Thursday)	74,952	USD 2,555,863	USD 2,555,863
2025-01-09 (Thursday)	74,952	USD 2,555,863	USD 2,555,863
2025-01-08 (Wednesday)	74,952	USD 2,555,863	USD 2,555,863
2025-01-08 (Wednesday)	74,952	USD 2,555,863	USD 2,555,863
2025-01-08 (Wednesday)	74,952	USD 2,555,863	USD 2,555,863
2025-01-02 (Thursday)	75,940	USD 2,634,359	USD 2,634,359	0	USD -17,466	USD 34.69	USD 34.92
2024-12-30 (Monday)	75,940	USD 2,651,825	USD 2,651,825	-2,939	USD -366,086	USD 34.92	USD 38.26
2024-12-10 (Tuesday)	78,879	USD 3,017,911	USD 3,017,911	0	USD -25,241	USD 38.26	USD 38.58
2024-12-09 (Monday)	78,879	USD 3,043,152	USD 3,043,152	0	USD 37,073	USD 38.58	USD 38.11
2024-12-06 (Friday)	78,879	USD 3,006,079	USD 3,006,079	0	USD 107,276	USD 38.11	USD 36.75
2024-12-05 (Thursday)	78,879	USD 2,898,803	USD 2,898,803	0	USD -31,552	USD 36.75	USD 37.15
2024-12-04 (Wednesday)	78,879	USD 2,930,355	USD 2,930,355	0	USD 105,698	USD 37.15	USD 35.81
2024-12-03 (Tuesday)	78,879	USD 2,824,657	USD 2,824,657	0	USD -22,875	USD 35.81	USD 36.1
2024-12-02 (Monday)	78,879	USD 2,847,532	USD 2,847,532	0	USD 29,185	USD 36.1	USD 35.73
2024-11-29 (Friday)	78,879	USD 2,818,347	USD 2,818,347	0	USD -13,409	USD 35.73	USD 35.9
2024-11-28 (Thursday)	78,879	USD 2,831,756	USD 2,831,756	0	USD 0	USD 35.9	USD 35.9
2024-11-27 (Wednesday)	78,879	USD 2,831,756	USD 2,831,756	0	USD 41,806	USD 35.9	USD 35.37
2024-11-26 (Tuesday)	78,879	USD 2,789,950	USD 2,789,950	0	USD -7,099	USD 35.37	USD 35.46
2024-11-25 (Monday)	78,879	USD 2,797,049	USD 2,797,049	0	USD 114,374	USD 35.46	USD 34.01
2024-11-22 (Friday)	78,879	USD 2,682,675	USD 2,682,675	0	USD 5,522	USD 34.01	USD 33.94
2024-11-21 (Thursday)	78,879	USD 2,677,153	USD 2,677,153	0	USD -115,164	USD 33.94	USD 35.4
2024-11-20 (Wednesday)	78,879	USD 2,792,317	USD 2,792,317	0	USD 130,151	USD 35.4	USD 33.75
2024-11-19 (Tuesday)	78,879	USD 2,662,166	USD 2,662,166	0	USD 1,577	USD 33.75	USD 33.73
2024-11-18 (Monday)	78,879	USD 2,660,589	USD 2,660,589	-3,780	USD -461,441	USD 33.73	USD 37.77
2024-11-12 (Tuesday)	82,659	USD 3,122,030	USD 3,122,030	0	USD -117,376	USD 37.77	USD 39.19
2024-11-08 (Friday)	82,659	USD 3,239,406	USD 3,239,406	-252	USD 50,649	USD 39.19	USD 38.46
2024-11-07 (Thursday)	82,911	USD 3,188,757	USD 3,188,757	0	USD -48,088	USD 38.46	USD 39.04
2024-11-06 (Wednesday)	82,911	USD 3,236,845	USD 3,236,845	0	USD 19,898	USD 39.04	USD 38.8
2024-11-05 (Tuesday)	82,911	USD 3,216,947	USD 3,216,947	0	USD 29,848	USD 38.8	USD 38.44
2024-11-04 (Monday)	82,911	USD 3,187,099	USD 3,187,099	0	USD -26,531	USD 38.44	USD 38.76
2024-11-01 (Friday)	82,911	USD 3,213,630	USD 3,213,630	0	USD 30,677	USD 38.76	USD 38.39
2024-10-31 (Thursday)	82,911	USD 3,182,953	USD 3,182,953	0	USD -72,133	USD 38.39	USD 39.26
2024-10-30 (Wednesday)	82,911	USD 3,255,086	USD 3,255,086	0	USD -37,310	USD 39.26	USD 39.71
2024-10-29 (Tuesday)	82,911	USD 3,292,396	USD 3,292,396	0	USD -53,892	USD 39.71	USD 40.36
2024-10-28 (Monday)	82,911	USD 3,346,288	USD 3,346,288	0	USD 97,006	USD 40.36	USD 39.19
2024-10-25 (Friday)	82,911	USD 3,249,282	USD 3,249,282	0	USD 34,823	USD 39.19	USD 38.77
2024-10-24 (Thursday)	82,911	USD 3,214,459	USD 3,214,459	0	USD 29,018	USD 38.77	USD 38.42
2024-10-23 (Wednesday)	82,911	USD 3,185,441	USD 3,185,441	0	USD -21,556	USD 38.42	USD 38.68
2024-10-22 (Tuesday)	82,911	USD 3,206,997	USD 3,206,997	0	USD -26,532	USD 38.68	USD 39
2024-10-21 (Monday)	82,911	USD 3,233,529	USD 3,233,529	-253	USD -66,419	USD 39	USD 39.68
2024-10-18 (Friday)	83,164	USD 3,299,948	USD 3,299,948

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of IONS by Blackrock for IE00BDZVHG35

Show aggregate share trades of IONS

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-04-23 BUY 264 29.100* 33.47
2025-04-10 SELL -2,112 26.710* 34.00 Profit of 71,803 on sale
2025-04-08 SELL -264 25.510* 34.17 Profit of 9,020 on sale
2025-04-07 SELL -264 27.570* 34.24 Profit of 9,040 on sale
2025-04-04 SELL -1,320 27.090* 34.33 Profit of 45,312 on sale
2025-04-01 BUY 2,314 27.260* 34.48
2025-03-31 SELL -780 30.170* 34.53 Profit of 26,936 on sale
2025-03-21 BUY 3,911 32.910* 34.72
2025-03-14 SELL -3,968 32.960* 34.82 Profit of 138,178 on sale
2025-03-07 SELL -494 33.810* 34.96 Profit of 17,268 on sale
2025-03-04 SELL -247 32.950* 35.02 Profit of 8,649 on sale
2025-02-25 BUY 496 31.850* 35.26
2025-02-19 SELL -247 31.810* 35.49 Profit of 8,766 on sale
2025-02-13 BUY 741 30.350* 35.84
2025-02-12 BUY 247 30.840* 35.94
2025-02-11 BUY 988 31.580* 36.04
2024-12-30 SELL -2,939 34.920* 37.34 Profit of 109,740 on sale
2024-11-18 SELL -3,780 33.730* 38.89 Profit of 147,004 on sale
2024-11-08 SELL -252 39.190* 38.95 Profit of 9,815 on sale
2024-10-21 SELL -253 39.000* 0.00
Market high and low price is on the date.

Date	Action	Quantity	Likely Trade Price	Average Price previous trades
2025-04-23	BUY	264	29.100*	33.47
2025-04-10	SELL	-2,112	26.710*	34.00 Profit of 71,803 on sale
2025-04-08	SELL	-264	25.510*	34.17 Profit of 9,020 on sale
2025-04-07	SELL	-264	27.570*	34.24 Profit of 9,040 on sale
2025-04-04	SELL	-1,320	27.090*	34.33 Profit of 45,312 on sale
2025-04-01	BUY	2,314	27.260*	34.48
2025-03-31	SELL	-780	30.170*	34.53 Profit of 26,936 on sale
2025-03-21	BUY	3,911	32.910*	34.72
2025-03-14	SELL	-3,968	32.960*	34.82 Profit of 138,178 on sale
2025-03-07	SELL	-494	33.810*	34.96 Profit of 17,268 on sale
2025-03-04	SELL	-247	32.950*	35.02 Profit of 8,649 on sale
2025-02-25	BUY	496	31.850*	35.26
2025-02-19	SELL	-247	31.810*	35.49 Profit of 8,766 on sale
2025-02-13	BUY	741	30.350*	35.84
2025-02-12	BUY	247	30.840*	35.94
2025-02-11	BUY	988	31.580*	36.04
2024-12-30	SELL	-2,939	34.920*	37.34 Profit of 109,740 on sale
2024-11-18	SELL	-3,780	33.730*	38.89 Profit of 147,004 on sale
2024-11-08	SELL	-252	39.190*	38.95 Profit of 9,815 on sale
2024-10-21	SELL	-253	39.000*	0.00

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of IONS

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-05-09	167,128	0	376,715	44.4%
2025-05-08	222,028	146	729,587	30.4%
2025-05-07	421,440	686	806,499	52.3%
2025-05-06	413,156	706	750,172	55.1%
2025-05-05	465,443	209	945,455	49.2%
2025-05-02	392,903	81	880,567	44.6%
2025-05-01	552,594	1,316	1,125,751	49.1%
2025-04-30	331,655	0	796,843	41.6%
2025-04-29	294,260	14,030	803,157	36.6%
2025-04-28	166,665	177	546,952	30.5%
2025-04-25	147,881	10,730	447,362	33.1%
2025-04-24	268,174	659	799,230	33.6%
2025-04-23	240,603	210	391,885	61.4%
2025-04-22	283,539	14,108	520,468	54.5%
2025-04-21	241,892	748	395,138	61.2%
2025-04-17	166,956	200	268,704	62.1%
2025-04-16	501,279	28,550	674,222	74.3%
2025-04-15	312,714	855	413,348	75.7%
2025-04-14	835,449	352	1,165,805	71.7%
2025-04-11	462,148	213	647,780	71.3%
2025-04-10	421,057	533	644,461	65.3%
2025-04-09	753,626	9,223	1,519,048	49.6%
2025-04-08	716,481	11,098	1,182,473	60.6%
2025-04-07	649,685	2,665	1,066,029	60.9%
2025-04-04	480,022	0	883,425	54.3%
2025-04-03	476,118	136	696,902	68.3%
2025-04-02	401,445	2,610	636,889	63.0%
2025-04-01	713,807	118	1,274,648	56.0%
2025-03-31	585,789	0	801,193	73.1%
2025-03-28	161,843	140	290,053	55.8%
2025-03-27	287,255	300	511,358	56.2%
2025-03-26	436,144	90	595,984	73.2%
2025-03-25	434,257	23	711,167	61.1%
2025-03-24	344,967	925	533,637	64.6%
2025-03-21	306,689	100	570,052	53.8%
2025-03-20	330,391	0	456,000	72.5%
2025-03-19	416,508	33	572,242	72.8%
2025-03-18	208,684	26	354,537	58.9%
2025-03-17	462,117	3,250	603,378	76.6%
2025-03-14	258,190	11,550	424,505	60.8%
2025-03-13	708,368	106	920,755	76.9%
2025-03-12	475,233	209	632,414	75.1%
2025-03-11	381,770	60	718,231	53.2%
2025-03-10	367,448	1,198	801,598	45.8%
2025-03-07	232,408	0	424,747	54.7%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer	Blackrock
ETF Ticker	BTEE(USD) LSE
ETF Ticker	BTEE.L(GBP) LSE